About
The Future of Precision Medicine Starts with Your Skin
Today, prescribing biologic drugs is a costly guessing game — one that’s growing rapidly as biologics are set to become the standard of care across many diseases. Trial and error treatment leads to wasted time, poor outcomes, and skyrocketing healthcare costs. DermaBio is changing this.
Our AI-powered precision medicine platform combines skin biomarker analysis, a proprietary clinical assay, and advanced data modeling to predict response to biologic therapies. This empowers smarter, faster, and more cost-effective care across multiple diseases.
Our data driven platform combines clinical assays and advanced data modeling to predict response from skin biomarker analysis. Our non-invasive skin swab integrates seamlessly into clinical workflows—fast, painless, and patient-friendly. Clinicians and payers get actionable data.
In short: One versatile platform. A win for clinicians, patients and payers.
Funding history · 2 rounds · — total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- When was DermaBio founded?
- DermaBio was founded in July 2022.
- What is DermaBio's primary focus?
- DermaBio focuses on delivering AI-based precision medicine through skin biomarkers and predictive modeling to predict response to biologic therapies.
- Where is DermaBio headquartered?
- DermaBio is headquartered in Jerusalem, Israel.
- Does DermaBio have offices outside of Israel?
- Yes, DermaBio has an office in Pittsburgh, PA, USA.
- What is DermaBio's current employee count?
- DermaBio currently has 6 employees.
- Which markets does DermaBio target geographically?
- DermaBio targets North America and Europe as its geographic markets.
- When did DermaBio complete its first funding round and who was a lead investor?
- DermaBio completed a Pre-Seed funding round in November 2022, with MindUP as a lead investor.
- What is the most recent funding round DermaBio has completed?
- DermaBio completed a Pre-Seed funding round in April 2025.
- What is DermaBio's current product stage?
- DermaBio's product is currently in the clinical trial stage.
- How many founders does DermaBio have?
- DermaBio has two founders: Miriam Oron Ph.D. and Meital Portugal.